MAP Autism Prediction Study

Exclusion Criteria

• •An individual who meets any of the following criteria will be excluded from participation in this study:
• •1. Previous diagnosis of ASD or DD
• •2. Prematurity \< 34 weeks' gestation
• •3. Has a sibling already enrolled in the trial
• •4. Profound sensory deficits (e.g., hearing and vision deficits) that could interfere with the interpretation of study results
• •5. Documented current or active seizures, as defined by a clinical seizure or abnormal EEG within the past six months
• •6. Major genetic defect as determined by chromosomal microarray or other method of genetic detection
• •7. Currently taking any high dose (greater than recommended daily allowance) dietary supplements
• •8. Diagnosis or suspicion of recent viral/bacterial infection within 2 weeks of enrollment
• •9. Diagnosis with congenital brain malformations, moderate to severe traumatic brain injury, congenital or acquired microcephaly, or infection of the central nervous system (e.g., meningitis, viral encephalitis)
• •10. Fetal alcohol syndrome, Down syndrome, or another recognized syndrome
• •11. Usage of acetaminophen (e.g., Tylenol) within the past 72 hours
• •12. Fever (temperature \> 100 degrees Fahrenheit) within the past 72 hours
• •13. Any other reason that the clinical investigator feels may place the participant at an unnecessary risk to participate